Michael West, MD
Clinical Cardiac Electrophysiology · Farmington, NMNPI 1902829021
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $50,000 of the $71,098 with a category attached, or 70.3%. Medtronic accounts for 79.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $23,746 and has fallen 64.1% since, to $8,518 in 2025.
Across 270 payments — averaging $263.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$57K
- Boston Scientific$4K
- Atricure, Inc.$2K
- GE HealthCare$2K
- Biosense Webster, Inc.$2K
- Medical Device Business Services, Inc.$2K
- plus $2K from 13 others
Across 55 payments — averaging $3996.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$220K
What the payments were for
- Royalty or licence$50,00070%
- Consulting fees$4,6887%
- Travel & lodging$7,47011%
- Food & beverage$8,94113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $56,785 |
| Boston Scientific | 99 | $3,970 |
| Atricure, Inc. | 16 | $2,427 |
| GE HealthCare | 4 | $2,250 |
| Biosense Webster, Inc. | 55 | $2,099 |
| Medical Device Business Services, Inc. | 9 | $1,918 |
| Heartflow, Inc. | 2 | $311 |
| Abbott | 2 | $260 |
| Cardiva Medical, Inc. | 8 | $228 |
| Cvrx, Inc. | 3 | $227 |
| Pfizer | 9 | $183 |
| Amgen | 6 | $101 |
| Novo Nordisk | 1 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $98 |
| Baxter Healthcare | 2 | $60 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| AstraZeneca | 1 | $19 |
| Novartis | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Attain$29,781
- ATTAIN COMMAND + SUREVALVE$20,000
- Carto 3$2,698
- ALLIA$2,042
- Farapulse$1,914
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,904
- WATCHMAN Access System$401
- FFRct$311
- AFFERA MAPPING SYSTEM$254
- AMPLATZER AMULET$237
- ATRICLIP LAA EXCLUSION SYSTEM$134
- WATCHMAN FLX$125
- Barostim Neo System$120
- VYNDAQEL$116
- Micra$111
- COBALT DR MRI SURESCAN$106
- Ozempic$100
How this compares
Too few clinical cardiac electrophysiology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 189 | $230,999 |
| EliquisApixaban | 56 | $68,764 |
| Flecainide Acetate | 122 | $4,625 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 58 | $1,981 |
| Metoprolol Succinate | 93 | $1,842 |
| Amiodarone Hcl | 52 | $933 |
| Atorvastatin Calcium | 25 | $407 |
| Metoprolol Tartrate | 31 | $318 |
| ClopidogrelClopidogrel Bisulfate | 14 | $302 |
| Carvedilol | 16 | $281 |
| Mupirocin | 21 | $264 |
| Losartan Potassium | 13 | $232 |
| Amlodipine Besylate | 11 | $212 |
| Atenolol | 16 | $186 |
| Prednisone | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $183 | $68,76456 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in New Mexicoon file to place this against a meaningful peer group, so we don't.
Other clinical cardiac electrophysiology in Farmington
- Michael PaikalFarmington$11K
- Chad BidartFarmington$5K
- Sean MazerAlbuquerque$274K
- Michael HoskinsAlbuquerque$84K
- Michael BestawrosAlbuquerque$82K
- Yaw Adjei-PokuAlbuquerque$52K
- Daniel LevinAlbuquerque$44K
- Michael GardnerAlbuquerque$17K
- Luis ConstantinAlbuquerque$10K
- Sandeep NairAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.